SB208 for the Treatment of Tinea Pedis
NCT02860052
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
222
Enrollment
INDUSTRY
Sponsor class
Conditions
Tinea Pedis
Interventions
DRUG:
SB208 2%
DRUG:
SB208 4%
DRUG:
SB208 16%
DRUG:
Vehicle Gel
Sponsor
Novan, Inc.